| Useful Advices |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Business > Collections Checklist: How to Collect Past-Due Accounts |
|
Useful Advices - Collections Checklist: How to Collect Past-Due Accounts
While having a small accounts-receivable balance indicates good
financial management, (around 1.5% to 2.5% of your gross income),
collecting past-due bala According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product nces is a displeasing aspects of business.
Studies show that 75% of receivables that are 3 months delinquent are
paid. However, this number drops to 56% ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in after 6 months. Therefore
your delay in collecting past-due accounts will reduce your chance of
receiving payment. This checklist should help you reduc lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. e the stress
of collecting past-due accounts:
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe discounts for accounts
paid within 10 days rather than 30 days. Keep an eye on the calendar for tax refund season. d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro or tax refund season. Most customers want to pay their bills and will pay if they have the money. ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc . Contact your attorney to ensure that you do not exceed your state’s usury statutes and federal law. easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi uss past-due accounts. Remember, that you value the client-relationship. nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ustomer’s business sense while respecting the valuable client relationship. For example, try “I’m the smallest of the smallest. I can’t play the role of ban and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ k because I am so small.” When you talk with your customer, offer some solutions. Give your client a way out of this uncomfortable situation. ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi y “good cop/bad cop”. Ask your secretary or partner to call on your behalf. This allows you to maintain the client relationship, while collecting your accou ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a nt. Ideally, the client will be so grateful to talk to you, the “good cop”, so they will not have to talk with the “bad cop”. dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod der letters. The first letter should include the following statements:
cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin that your valued client has allowed his/her account to lapse tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen s/her credit status is in jeopardy (include your contact information) t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel a collection attorney. Say, “we regret having to take this action, but must do so” ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust our subsequent letters should include several choice boxes:
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products faith. . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de for small claims is $10,000. Corporations and associations with less than a $2500 claim, do not need an attorney to represent them in small claims court. elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip I> tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:The Time Dimension - Presented Versus 1991 Zip Codes Guide to Purchasing and Leasing Copiers Value Stream Mapping Explained
|